Martin Kelly, Ph.D., Receives 2018 Biomedical Innovation Program Drug Discovery Award

Three drug discovery projects have been named recipients of the 2018 Biomedical Innovation Program awards. The awards program is a collaboration of the Oregon Clinical and Translational Research Institute and Technology Transfer and Business Development.

The awards provide funds, project management, and mentorship to facilitate the development of innovative technologies at OHSU and accelerate their translation to the marketplace. This track of funding supports drug discovery platforms and early stage therapeutic technology projects.

2018 BIP Drug Discovery awardees:

  • Martin Kelly, Ph.D., professor of physiology and pharmacology, School of Medicine
  • Stephen Lloyd, Ph.D., professor, Oregon Institute of Occupational Health Sciences, Department of Molecular and Medical Genetics, School of Medicine
  • Arthur Vandenbark, Ph.D., professor of neurology and molecular microbiology and immunology, School of Medicine, senior research scientist, Portland VA Medical Center
     

By prioritizing commercialization outcomes, the BIP helps position technologies to have the best possible chance of making it to market and improving human health.

Detailed information on the awards is available on the OCTRI website.